Celldex Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -12.95 | -100% |
| P/S |
|
277.9 | 33.76 | 723.22% |
|
|
| P/BV |
|
4.46 | 4.82 | -7.55% |
|
|
| P/FCF |
|
-13.11 | 60.98 | -121.49% |
|
|
| Ev/Ebitda |
|
-13.53 | -22.12 | -38.86% |
|
|
| Ev/S |
|
273.21 | 22.56 | 1110.86% |
|
|
| Ev/FCF |
|
-17.24 | 68.75 | -125.07% |
|
|
| E/P |
|
-0.0989 | 0.0178 | -656.44% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-2019.96 | 4.83 | -41917.99% | -1824.91 | 10.69% |
| ROE |
|
-32.95 | 9.61 | -443.05% |
|
|
| ROA |
|
-30.37 | 0.3359 | -9142.39% |
|
|
| ROIC |
|
-25.76 | 7.63 | -437.42% |
|
|
| ROS |
|
-2054.76 | -25.17 | 8063.49% |
|
|
| ROCE |
|
-33.1 | 15.33 | -315.88% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0183 | -3.67 | -99.5% | -0.0364 | -49.82% |
| Nеt Debt/Ebitda |
|
0.2321 | -3.44 | -106.75% |
|
|
| Debt/Ratio |
|
0.0055 | 0.1972 | -97.23% |
|
|
| Debt/Equity |
|
0.008 | 1.65 | -99.51% |
|
|
| Debt/Net Income |
|
-0.018 | 10.31 | -100.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5491 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5491 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
8/10
|
72.08 | -56.89 | -226.7% |
| Growth impulse Ebitda 5 years |
|
202.12 | -64.81 | -411.87% |
| Growth impulse Net Income 5 years |
|
177.31 | -58.33 | -403.98% |
| Growth impulse FCF 5 years |
|
132.15 | -47 | -381.17% |
| Growth impulse EPS 5 years |
|
-16.83 | -32.41 | -48.07% |
IP Score
4.05/10
